Predictors and Patterns of Hilar Lymph Node Metastasis by Tumour Location in Clinical Stage IA Pure-solid Non-small-cell Lung Cancer
European Journal of Cardio-Thoracic Surgery · 2025
DOI: 10.1093/ejcts/ezaf361 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cardio-Thoracic Surgery, 2025. Verfasst von Takahiro Niimi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Juntendo University School of Medicine, Bunkyoku, Tokyo 113-0013, Japan. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Lymph Nodes. Die Arbeit nennt 34 Literaturangaben. Gefördert von: JSPS KAKENHI, Practical Research for Innovative Cancer Control Fund of the Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
Objectives
Segmentectomy for radiologically pure-solid non-small-cell lung cancer remains controversial due to the high rate of occult lymph node metastasis. Certain hilar lymph nodes (HLN) can be challenging to resect during segmentectomy, especially non-adjacent interlobar lymph node (non-aiLN) distant from the primary tumour. We aimed to elucidate whether HLN metastasis can be predicted more accurately in clinical stage IA pure-solid tumours.
Methods
Between 2009 and 2023, 693 consecutive patients with clinical stage IA pure-solid tumours who underwent lobectomy with HLN dissection were included. The frequencies of HLN and non-aiLN metastases were evaluated. Predictors of HLN metastasis were assessed using multivariable logistic regression analysis.
Results
HLN and non-aiLN metastases were detected in 110 (15.9%) and 34 patients (4.9%), respectively. Multivariable logistic regression analysis revealed that carcinoembryonic antigen (CEA) level (P < .01), left side (P = .04), maximum standardized uptake value (SUVmax) (P < .01), and adenocarcinoma (P < .01) were independent predictors of HLN metastasis. Furthermore, in tumours with high SUVmax >5.0 and CEA >5.0 ng/mL, based on the results of the multivariable logistic regression model, the frequency of HLN metastasis increased to 23.0% (28/122). Additionally, 9 (32.1%) tumours had non-aiLN metastases.
Conclusions
HLN and non-aiLN metastases were frequent among clinical stage IA pure-solid tumours, especially in those with SUVmax >5.0 and CEA >5.0 ng/mL. HLN dissection during segmentectomy should be performed carefully in patients with clinical stage IA pure-solid tumours with high SUVmax and CEA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Thoracic Surgery, Juntendo University School of Medicine, Bunkyoku, Tokyo 113-0013, Japan.
ORCID-Profile: Mariko Fukui, Takeshi Matsunaga, Kazuya Takamochi, Kenji Suzuki
Förderung
- JSPS KAKENHI
- Practical Research for Innovative Cancer Control Fund of the Japan Agency for Medical Research and Development
Zitieren
APA
Niimi, T., Hattori, A., Fukui, M., Matsunaga, T., Takamochi, K., Tomita, H., & Suzuki, K. (2025). Predictors and Patterns of Hilar Lymph Node Metastasis by Tumour Location in Clinical Stage IA Pure-solid Non-small-cell Lung Cancer. European Journal of Cardio-Thoracic Surgery. https://doi.org/10.1093/ejcts/ezaf361
Vancouver
Niimi T, Hattori A, Fukui M, Matsunaga T, Takamochi K, Tomita H, et al. Predictors and Patterns of Hilar Lymph Node Metastasis by Tumour Location in Clinical Stage IA Pure-solid Non-small-cell Lung Cancer. European Journal of Cardio-Thoracic Surgery. 2025. doi:10.1093/ejcts/ezaf361
BibTeX
@article{Niimi2025,
author = {Niimi, Takahiro and Hattori, Aritoshi and Fukui, Mariko and Matsunaga, Takeshi and Takamochi, Kazuya and Tomita, Hisashi and Suzuki, Kenji},
title = {Predictors and Patterns of Hilar Lymph Node Metastasis by Tumour Location in Clinical Stage IA Pure-solid Non-small-cell Lung Cancer},
journal = {European Journal of Cardio-Thoracic Surgery},
year = {2025},
doi = {10.1093/ejcts/ezaf361}
}
EUVIMED